Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | PHLDA2 |
| Upstream (Parents) |
|---|
| (<<) KRT19///JUP → PHLDA2 |
| (<<) S100A6 → PHLDA2 |
| Downstream (Children) |
|---|
| PHLDA2 → TNFRSF21 (>>) |
| PHLDA2 → FUT8 (>>) |
| PHLDA2 → RHOF (>>) |
| PHLDA2 → FOSL1 (>>) |
| PHLDA2 → CDH3 (>>) |
| PHLDA2 → PKM2 (>>) |
| PHLDA2 → EPHA2 (>>) |
| PHLDA2 → GDPD3 (>>) |
| PHLDA2 → MALL (>>) |
| PHLDA2 → PLCB3 (>>) |
| PHLDA2 → HN1 (>>) |
